SCHEMBL22930604

SCHEMBL22930604

c1ccc2c(c1)-c1ccccc1C21c2ccccc2C2(c3ccccc3-c3cc4c(cc32)oc2ccccc24)c2ccccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.50
MAPT P10636 6/20 0.46
MEN1 O00255 5/20 0.46
KMT2A Q03164 5/20 0.46
KDM4E B2RXH2 4/20 0.46
ALDH1A1 P00352 3/20 0.46
HPGD P15428 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 1/20 0.46
PGR P06401 1/20 0.43
MAOA P21397 3/20 0.39
CYP1A2 P05177 2/20 0.36
GLA P06280 1/20 0.36
CYP3A4 P08684 1/20 0.36
PGAM1 P18669 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
HSD17B10 Q99714 1/20 0.36
LMNA P02545 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16491652 0.98 AHR (0.51) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL18731701 0.95 AHR (0.51) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL16491690 0.93 AHR (0.53) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL13467921 0.92 AHR (0.51) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL14681708 0.91 AHR (0.45) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL22617611 0.91 MAPT (0.45) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL22617635 0.91 AHR (0.45) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL19886880 0.91 MAPT (0.44) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL18732019 0.90 AHR (0.53) AHRMAPTMEN1KMT2AKDM4E
SCHEMBL18732016 0.90 AHR (0.53) AHRMAPTMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10910567-B2 Double spiro-type compound and organic light emitting diode comprising same LG CHEM, LTD. 2021-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10910567-B2 Double spiro-type compound and organic light emitting diode comprising same NR2E3, ALDH1A2, CRY1 AHR 668/4885MAPT 1561/4885MEN1 1825/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.